Vineet Laboratories Ltd
Fri 5/12/2025,15:52:31 | NSE : VINEETLAB
Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
Open
₹ 41.56
Previous Close
₹ 41.19
Volume
34846
Mkt Cap ( Rs. Cr)
₹38.58
High
₹ 42.10
Low
₹ 41.05
52 Week High
₹ 64.69
52 Week Low
₹ 26.51
Book Value Per Share
₹ 15.89
Dividend Yield
0.00
Face Value
₹ 10.00
What’s Your Call?
Collective community sentiment on Vineet Laboratories Ltd
Your Vote -
Buy
33.33%
Hold
0.00%
Sell
66.67%
33.33%
3 users have voted
Market Depth
How many stocks are available to buy or sell and at what prices.
Buy Order Quantity
0%
Sell Order Quantity
100%
Bid Price
Qty
0.00
0
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
0
Bid Price
Qty
41.85
354
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
354
Option Chain
Analyzes market sentiment, predicts Vineet Laboratories Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Vineet Laboratories - Committee Meeting Updates
-
Vineet Laboratories - Announcement under Regulation 30 (LODR)-Meeting Updates
-
Vineet Laboratories - Prior Intimation Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulati
-
Vineet Laboratories - Committee Meeting Updates
-
Vineet Laboratories - General Updates
-
Vineet Laboratories - Rights Issue
-
Vineet Laboratories - Issue of Securities
-
Vineet Laboratories - Outcome of Board Meeting
-
Vineet Laboratories - Intimation Of Submission Of Draft Letter Of Offer For The Proposed Rights Issue
-
Vineet Laboratories - Announcement under Regulation 30 (LODR)-Raising of Funds
-
Vineet Laboratories - Announcement under Regulation 30 (LODR)-Issue of Securities
-
Vineet Laboratories - Board Meeting Intimation for Fund Raising By Way Of Issue Of Equity Shares Through Rights Issue.
-
Vineet Laboratories - Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Regulations, 2015
-
Vineet Laboratories - Updates
-
Vineet Laboratories - Copy of Newspaper Publication
-
Vineet Laboratories - Appointment
-
Vineet Laboratories posts Q2 net profit of Rs 0.40 cr
-
Vineet Laboratories - Resignation
-
Vineet Laboratories - Announcement under Regulation 30 (LODR)-Change in Management
-
Vineet Laboratories - Announcement under Regulation 30 (LODR)-Resignation of Director
-
Vineet Laboratories - Resignation of Independent director
-
Vineet Laboratories - Unaudited Standalone Financial Results Of The Company For The Second Quarter And The Half Year Ended On
-
Vineet Laboratories - Outcome of Board Meeting
-
Vineet Laboratories - Outcome of Board Meeting
-
Vineet Laboratories - Board Meeting Outcome for Outcome Of Board Meeting Held On Saturday, November 08, 2025 As Required Unde
-
Vineet Laboratories - Board Meeting Intimation for Considering The Unaudited Standalone Financial Results Of The Company For
-
Vineet Laboratories has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2025
-
Vineet Laboratories - Cancellation of Board Meeting
-
Vineet Laboratories - Certificate under SEBI (Depositories and Participants) Regulations, 2018
-
Vineet Laboratories - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Vineet Laboratories - Board Meeting Intimation for Considering The Unaudited Standalone Financial Results Of The Company For
-
Vineet Laboratories - Updates
-
Vineet Laboratories - Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Regulations, 2015
-
Vineet Laboratories - Trading Window
-
Vineet Laboratories - Updates
-
Vineet Laboratories - Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Regulations, 2015 - Mr. S
-
Vineet Laboratories - Shareholders meeting
-
Vineet Laboratories - Shareholder Meeting / Postal Ballot-Scrutinizer's Report
-
Vineet Laboratories - Change in Management
-
Vineet Laboratories - Change in Auditors
-
Vineet Laboratories - Announcement under Regulation 30 (LODR)-Change in Management
-
Vineet Laboratories - Shareholders meeting
-
Vineet Laboratories - Shareholder Meeting / Postal Ballot-Scrutinizer's Report
-
Vineet Laboratories - Shareholder Meeting / Postal Ballot-Outcome of AGM
-
Vineet Laboratories - Shareholder Meeting / Postal Ballot-Scrutinizer's Report
-
Vineet Laboratories - Shareholders meeting
-
Vineet Laboratories - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report
-
Vineet Laboratories - Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
-
Vineet Laboratories - Change in Director(s)
-
Vineet Laboratories - Announcement under Regulation 30 (LODR)-Change in Management
Key fundamentals
Evaluate the intrinsic value of Vineet Laboratories Ltd stock
| Name | March-25 | March-24 | March-23 | March-22 | March-21 |
|---|---|---|---|---|---|
| Assets | 54.6947 | 79.0239 | 64.7723 | 59.7318 | 39.0878 |
| Liabilities | 54.6947 | 79.0239 | 64.7723 | 59.7318 | 39.0878 |
| Equity | 9.219 | 9.219 | 9.219 | 9.219 | 9.219 |
| Gross Profit | -16.2831 | 7.2002 | 7.6597 | 13.2445 | 8.1456 |
| Net Profit | -20.191 | 1.0271 | 1.2525 | 6.6386 | 1.7802 |
| Cash From Operating Activities | 11.4909 | -11.4272 | -9.6162 | 0 | -8.7123 |
| NPM(%) | -26.92 | 0.68 | 0.58 | 3.47 | 0.73 |
| Revenue | 74.995 | 150.5913 | 212.2933 | 191.1723 | 243.4789 |
| Expenses | 91.2781 | 143.3911 | 204.6336 | 177.9278 | 235.3333 |
| ROE(%) | -137.84 | 7.01 | 8.55 | 45.32 | 12.15 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|---|---|---|---|
| 19 Sep 2022 | 1 | 10 | 0 | 58.75 |
Peers
Other companies within the same industry or sector that are comparable to Vineet Laboratories Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 783.55 | 1.48 | 0.00 | 24.11 | 301.39 | 0.64 |
| Lotus Eye Hospital and Institute Ltd | 105.71 | 0.17 | 330.34 | 87.86 | 3.55 | 0.00 |
| Vaishali Pharma Ltd | 8.42 | -2.55 | 0.00 | 551.20 | 3.13 | 0.00 |
| Astec Lifesciences Ltd | 760.65 | -6.66 | 0.00 | 82.86 | -604.77 | 0.00 |
Company Info
Vineet Laboratories Limited ("Resulting Company") is a public limited company incorporated under the provisions of the Companies Act, 2013, on 10th day of November, 2016. The Corporate Identity Number of Resulting Company is U24304TG2016PLC112888. The objects of the Resulting Company enable it to carry on the business of manufacturing of bulk drugs intermediates and API Intermediates. The PAN of the Company is AAFCV6694P.
Vineet Laboratories Limited ("Resulting Company") is a public limited company incorporated under the provisions of the Companies Act, 2013, on 10th day of November, 2016. The Corporate Identity Number of Resulting Company is U24304TG2016PLC112888. The objects of the Resulting Company enable it to carry on the business of manufacturing of bulk drugs intermediates and API Intermediates. The PAN of the Company is AAFCV6694P.
Read More
Parent Organisation
Vineet Laboratories Ltd.
Founded
10/11/2016
Managing Director
Mr.Gaddam Venkata Ramana
NSE Symbol
VINEETLABEQ
FAQ
The current price of Vineet Laboratories Ltd is ₹ 41.85.
The 52-week high for Vineet Laboratories Ltd is ₹ 42.10 and the 52-week low is ₹ 41.05.
The market capitalization of Vineet Laboratories Ltd is currently ₹ 38.58. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Vineet Laboratories Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Vineet Laboratories Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Vineet Laboratories Ltd shares.
The CEO of Vineet Laboratories Ltd is Mr.Gaddam Venkata Ramana, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.